BioCentury | Jan 16, 2021
Product Development
Arcus’ CD73 inhibitor challenges AZ’s oleclumab, at least six others follow in oncology: Data Byte
...in the first-line setting.At the 2018 meeting of the American Society of Clinical Oncology, AstraZeneca plc...
...in Phase I testing for COVID-19. " title="Interactive or visual content" frameborder="0" scrolling="no" style="width:100%;height:900px;"> Selina Koch AstraZeneca plc Arcus...
...in Phase I testing for COVID-19. " title="Interactive or visual content" frameborder="0" scrolling="no" style="width:100%;height:900px;"> Selina Koch AstraZeneca plc Arcus...